Navigation Links
Patient-Centric Healthcare Study Reveals Key Insights for Pharmaceutical Marketers
Date:1/7/2008

10,000 patient study taps into power of patient in making healthcare

decisions

WILTON, Conn., Jan. 7 /PRNewswire/ -- Ryan TrueHealth (http://www.ryantruehealth.com), the healthcare communications division of Ryan Partnership, a national marketing services firm, announces the findings of its landmark on-line "Patient Power" healthcare study. In partnership with ICOM, Ryan TrueHealth fielded the 10,000 patient study to help marketers tap into how patients make healthcare decisions, what the key influencers are and why.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080107/NEM006 )

Fielded among patients with at least one chronic condition, the patient power study yielded the following results:

-- Despite differences in chronic conditions, patients refer to the same

trusted information sources when making healthcare decisions.

-- While healthcare professionals and experts are still the most trusted,

peers, spouses, and friends are the second-most trusted source for

healthcare decision-making.

-- Advocates play a highly influential role in motivating other patients

because they are natural information gatherers and disseminate what

they learn.

-- Authentic communications with patients helps marketers meet patients'

needs for trust while they look for authenticity.

-- Spiritual beliefs are an important source in patient decision making.

-- Patients want information that is personalized. Marketers who deliver

the right information to the right customer at the right time create

opportunities for ongoing communications.

"The consumer and patient landscape is changing rapidly, and how people make healthcare decisions and whom they trust gives us insight into some of the deeper needs of the patient. The results reveal that patients are more alike than dissimilar in their healthcare decision making process. From patients with high blood pressure to those suffering daily with rheumatoid arthritis, the human condition trumps the disease condition. These survey findings reveal what pharmaceutical marketers are looking for - the kind of insight that spans condition," Alfred O'Neill, Senior Vice President, Ryan TrueHealth, concluded.

About Ryan TrueHealth

Ryan TrueHealth is a full-service healthcare communications company that creates strategic Relationship Marketing solutions for pharmaceutical, biotech, OTC brands and health insurance companies. The agency creates engaged, trusting and profitable relationships between clients and their customers -- embracing an Insight to Measurement approach that takes a 360 degree view of audience needs and surrounds every creative program with rigorous measurement.

Ryan TrueHealth is backed by the resources of the Ryan Partnership, which includes 9 offices, 425 employees and $200MM in revenues. Their experience in creating brand value includes Unilever's Dove.com, Callwaysgolftv.com and Very Best Kids RM program for Kraft.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Alfred O'Neill http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=71570


'/>"/>
SOURCE Ryan TrueHealth
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Warner Chilcott to Present at the 26th Annual JPMorgan Healthcare Conference
2. Map the Canadian Healthcare IT Market with the New HIMSS Analytics Canadian Database(SM)
3. Covance to Present at 26th Annual JPMorgan Healthcare Conference
4. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
5. Perrigo Company to Present at The 26th Annual JPMorgan Healthcare Conference
6. Michigan Quality Council (MQC) Names Oakwood Healthcare Inc. 2007 State Quality Award Recipient
7. InfoLogix Featured in FOX Business News Interview on Reducing Healthcare Medication Errors - Video Available Online
8. DaVita Inc. to Present at JPMorgan Healthcare Conference
9. Hologic to Present at the 26th Annual JP Morgan Healthcare Conference
10. Neurochem to present at JPMorgan Healthcare Conference
11. MedCath Corporation to Present at the 26th Annual JPMorgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: